Evoke Pharma, Inc. (EVOK) Stock Analysis & Investment Frameworks
Evoke Pharma, Inc. (EVOK) stock analysis on Invetso. Review Evoke Pharma, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Evoke Pharma, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
Evoke Pharma, Inc. Key Financial Metrics
- Market Cap: $18.95M
- Revenue: $10.25M
- ROE: -70.50%
- ROIC: -31.82%
- Dividend Yield: N/A
About Evoke Pharma, Inc.
Evoke Pharma, Inc. operates as a specialized pharmaceutical entity, primarily focused on inventing and bringing to market therapeutic agents for various digestive system illnesses. The company's lead development candidate is Gimoti, a metoclopramide nasal spray, which has progressed through and completed its Phase 3 clinical trials. This medicine is being developed to mitigate symptoms associated with both acute and recurring diabetic gastroparesis, specifically in female patients. Evoke Pharma distributes its offerings to a broad base of healthcare professionals, encompassing digestive disease specialists, internists, general practitioners, and certain other medical providers. Established in 2007, the company's corporate offices are situated in Solana Beach, California.